PLAU transcript levels were significantly decreased in UHRF1 KO osteosarcoma cells (Supplementary Fig. 6E) and subcutaneous xenografts, with an average 2.2-fold decrease compared to VC cell-derived tumors (P = 0.038, Fig. 4G). This evidence concerns the gene UHRF1 and osteosarcoma.